Latest News

 Filter by Provider

The dollar has traded heavily in recent days, and it is consolidating in narrow ranges with a slightly firmer bias today.

Fossil Group insiders are buying stock, indicating increased confidence in the business's ability to create value. Institutions are also buying.

Despite O'Reilly Automotive’s recent underperformance relative to the Nasdaq, analysts remain highly optimistic about the stock’s prospects.

Bryn Talkington of Requisite Capital Management picked Nike. Wells Fargo recently upgraded Nike from Equal-Weight to Overweight.

The offer represents an 82% premium over the company’s 60-day volume-weighted average price as of December 1.

On Holding (ONON) exemplifies a growth stock with strong fundamentals and a potential technical breakout, signaling market momentum.

Grayscale has shot down Bitcoin (CRYPTO: BTC) price crash predictions, predicting that the next major leg could take prices

The WisdomTree U.S. LargeCap Dividend Fund is a unique though seasoned offering in the dividend ETF category.

Oil prices are starting to fade recent gains, with WTI turning lower from the $60 handle ahead of key US-Russia negotiations in Moscow.

American Eagle offers an annual dividend yield of 50 cents. Investors can exploit its dividend yield to pocket $500 monthly. Here's how.

On Dec. 1, Klarna shares fell 4.6% to settle at $30.04; while Newmont shares gained 1.2% to settle at $91.83.

Costco is suing the Trump administration, challenging the legality of tariffs imposed under the International Emergency Economic Powers Act.

Did you get your flu shot this year? You might think that having the flu (influenza) just means a bad cold or cough. But the truth is that flu can be serious and could cause unpredictable symptoms. It can disrupt your daily life and even be life-threatening,[1] which is why taking steps to help protect yourself, like getting your annual flu vaccine, is so important.

Oracle stock is coming off a brutal month, with shares sliding more than 20% in November and starting December with a loss.

Eightco Holdings (ORBS) value score surges despite 90% 6-month gain. Dan Ives-led Worldcoin treasury play still undervalued.

Check out the companies making headlines yesterday:

Shares of BridgeBio Pharma are nearing a record high as the small biotech company takes on drug behemoths Pfizer and Alnylam.

Our top technical analyst explains how midterm elections could change the picture during the seasonally bullish November-April stretch.

The Boston-based tech company is gaining traction in its mission to modernize lithium batteries.

The EUR/USD pair retreated to 1.1612 on Tuesday, pulling back from a recent two-week high.

Third-quarter results and fourth-quarter guidance have reinforced confidence in MongoDB’s potential in the AI-driven software market.

McKesson Corp exemplifies GARP investing, offering strong earnings growth at a reasonable valuation, backed by solid profitability and financial strength.

The Reserve Bank of Australia’s final interest rate call of the year is coming up.

These healthcare leaders can make you money while you sleep.

Mueller Industries (MLI) combines strong fundamentals like zero debt and high profitability with positive technical momentum and market-beating performance.

Alphabet has outperformed other mega-cap stocks over the past year. Moreover, Wall Street analysts remain strongly optimistic about its prospects.

Headline inflation increased from 2.1 to 2.2% in November, while core inflation remained stable at 2.4%.

The Federal Reserve officially ended its Quantitative Tightening program on December 1, 2025, freezing its balance sheet at $6.57 trillion and marking a pivotal shift in monetary policy that could reshape Bitcoin (CRYPTO:

In a filing with the Securities and Exchange Commission, YZi Labs argued the current board has underperformed and failed to act in shareholders’ best interests.

Though MetLife has fallen behind the financial sector over the past year, Wall Street analysts maintain a moderately optimistic outlook on its prospects.

Cybersecurity has become the goldmine of software infrastructure, as escalating risk events push companies to spend without hesitation.

Veracyte (VCYT) exemplifies GARP investing with strong cancer diagnostic growth, reasonable valuation vs. biotech peers, and a debt-free financial foundation.

Mercury Marine renews exclusive engine-supply agreements with Saxdor Yachts and Axopar Boats, showcasing new releases at major boat shows.

A 134% revenue surge and a $55.6 billion backlog show CoreWeave’s AI cloud is booked solid for years.

These stocks look poised to outperform the S&P 500 over the long run.

The Pound Sterling faces pressure against its major currency peers amid dovish BoE expectations.

Signet Jewelers beats Q3 earnings forecasts and raises full-year outlook, driven by strong pricing and brand growth, despite a cautious holiday sales forecast.

The company's finally got some credible competition, with more waiting in the wings.

MasTec (MTZ) combines strong earnings growth and rising profit margins with a bullish technical chart, offering a potential high-growth momentum opportunity.

BlackBerry QNX secures a key design win with a top Chinese automaker, integrating scalable audio software into next-gen luxury EVs for 2026.

The quantum computing company has rewarded early investors.